InvestSMART

Bio-Gene Technology Ltd (ASX: BGT) - Announcements

- Current share price for BGT : $0.014

ASX company news and announcements for Bio-Gene Technology Ltd (BGT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bio-Gene Technology Ltd (BGT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bio-Gene Technology Ltd (BGT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bio-Gene Technology Ltd (BGT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Appendix 4D - Half Year Accounts - 31 December 2021 17 Feb 2022 10:29AM $0.220 $0.014 fallen by 93.64%
$6 Bio-Gene Receives R&D Tax Incentive 9 Feb 2022 9:29AM $0.230 $0.014 fallen by 93.91%
$6 Bio-Gene Announces Appointment of Head of Regulatory Affairs 7 Feb 2022 8:55AM $0.220 $0.014 fallen by 93.64%
$6 Appendix 4C - 31 December 2021 31 Jan 2022 10:00AM $0.200 $0.014 fallen by 93%
$6 Results of Meeting - EGM 27 Jan 2022 12:14PM $0.205 $0.014 fallen by 93.17%
$6 Notification of cessation of securities - BGT 20 Dec 2021 8:22AM $0.190 $0.014 fallen by 92.63%
$6 EGM 270122 - Shareholder Letter, Notice of Meeting and Proxy 17 Dec 2021 12:23PM $0.180 $0.014 fallen by 92.22%
$6 Cleansing Statement 17 Dec 2021 12:17PM $0.180 $0.014 fallen by 92.22%
$6 Application for quotation of securities - BGT 17 Dec 2021 12:12PM $0.180 $0.014 fallen by 92.22%
$6 Proposed issue of securities - BGT 9 Dec 2021 9:04AM $0.200 $0.014 fallen by 93%
$6 Bio-Gene Completes Capital Raising of $3.2 Million 9 Dec 2021 9:04AM $0.200 $0.014 fallen by 93%
$6 Trading Halt 7 Dec 2021 9:05AM $0.200 $0.014 fallen by 93%
$6 Bio-Gene to Progress Synergy Research 6 Dec 2021 9:18AM $0.195 $0.014 fallen by 92.82%
$6 Appendix 3G 1 Dec 2021 2:03PM $0.205 $0.014 fallen by 93.17%
$6 Bio-Gene Virtual Presentation at V-Con 1 Dec 2021 12:20PM $0.215 $0.014 fallen by 93.49%
$6 Results of Meeting 30 Nov 2021 2:14PM $0.205 $0.014 fallen by 93.17%
$6 Bio-Gene 2021 AGM - CEO's Presentation 30 Nov 2021 10:54AM $0.210 $0.014 fallen by 93.33%
$6 Bio-Gene 2021 AGM - Chairman's Address 30 Nov 2021 10:53AM $0.210 $0.014 fallen by 93.33%
$6 Bio-Gene 2021 AGM Presentation 30 Nov 2021 10:53AM $0.210 $0.014 fallen by 93.33%
$6 2021 Notice of Annual General Meeting/Proxy Form 29 Oct 2021 2:42PM $0.190 $0.014 fallen by 92.63%
$6 Bio-Gene Investor Briefing 28 Oct 2021 11:07AM $0.200 $0.014 fallen by 93%
$6 Appendix 4C - 30 September 2021 28 Oct 2021 8:17AM $0.190 $0.014 fallen by 92.63%
$6 Bio-Gene Technology Investor Briefing 27 Oct 2021 9:05AM $0.195 $0.014 fallen by 92.82%
$6 Bio-Gene Executes Option Agreement with Clarke 27 Oct 2021 8:37AM $0.195 $0.014 fallen by 92.82%
$6 Bio-Gene Commercial Agreement with Evergreen Garden Care 25 Oct 2021 8:24AM $0.145 $0.014 fallen by 90.34%

251 - 275 of 485 results

Page 11 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.